Upgrade to SI Premium - Free Trial

Allergan (AGN) PT Cut To $189 At Wells Fargo After Rapastinel Misses Endpoints

March 7, 2019 8:55 AM
Wells Fargo analyst, David Maris, reiterated his Outperform rating on shares of Allergen (NYSE: AGN) and cut his PT to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles